|
Usually CTs are aimed primarily at seeking the best medication for the research participants
|
0.703
|
|
I would participate in CTs, because then I would receive the best treatment for me
|
0.673
|
|
I would like to participate in CTs in order to determine the continuation of my current treatment relationship
|
0.643
|
|
In CTs, all participants always receive a new effective agent
|
0.638
|
|
In CTs, the physician conducting the research may choose which drug the participant receives
|
0.564
|
|
Often, the patient participating in the research may choose which drug they receive
|
0.540
|
|
I would participate only in a CT in which at least one of the drugs being compared has been shown to be effective
|
0.525
|
|
I would participate in a CT only if the treating physician also is the investigator
|
0.485
|
|
I would participate in a CT if that guaranteed me new and improved medication
|
0.476
|
|
I would like to participate in a CT because then I would receive more thorough monitoring relative to standard treatment
|
0.469
|
|
I would participate in a CT only if I were not satisfied with my current medication
|
0.468
|
|
In CTs, the physician conducting the research is aware of whether the participant is receiving a new drug, a placebo (which does not include an effective agent), or an older Parkinson’s disease medication
|
0.437
|
